Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by bfwon May 27, 2021 12:15pm
54 Views
Post# 33275967

RE:RE:RE:RE:RE:RE:RE:RE:RE:More volume/higher valuation? This is how to get there.

RE:RE:RE:RE:RE:RE:RE:RE:RE:More volume/higher valuation? This is how to get there.

 

Agreed. 


He has nothing to brag about given he was trying to get everyone out of TH and in to GLPG. 


That chart shows a bigger collapse than even TH's high a few years ago!

bfw

Bucknelly21 wrote:

canadapiet wrote: SPCEO1 - (5/27/2021 11:20:48 AM) 
RE:RE:RE:RE:RE:RE:More volume/higher valuation? This is how to get there.
I don't know. I am not sure that really was the whole issue anyway. I think they saw the January 6th attack on the capitol in DC and overreacted due to the chance that would lead the markets to collapse and cause the window for them to access funds easily close. From the board of directors perspctive, they were likely seeing themselves as well into overtime to be cashing up in preparation for the spending on cancer and NASH R&D. Also, we have seen a lot of hiring going on and the desire to cash up fast also likely reflected Paul's desire to build out a more robust team. Luc was very careful with how he spent money but Paul comes from a big company and was not used to such a lean supporting cast. You likely have noticed how many Executive Assistants they are hiring - I would not have thought the need for those was a thing anymore. So, hopefully Paul's confidence on cancer turns into reality as they will never be short of funding if that is the case. If not, TH will have a long and expensive NASH trial ahead of it and raising new money will be feasible but will likely at a price that we may not like very much. If cancer is a winner, however, partnership money will be flowing and price of new cash will not be much of an issue as big pharma will be anxious to get a piece of TH's PDC cancer action. As I have said previously, it might be that big pharma will just want to buy TH out altogether if cancer looks intriguing later this year. If a big pharma offers a high enough bid, the board' of directors's lawyers will alost certainly tell them they need to let shareholders decide whether to sell or not. So, we may get to decide whether to sell or not if cancer is a winner. That could be interesting!


Truly amasing your support to this company Mr. SPCEO........Years have passed, the longest bull market ever, companies gaining from the capital market, many companies doing really amazing things in oncology, shareholders get respect and are being informed how things are going......etc etc !!!!

And what do we know/get from our beloved BOD ??????

Really amazing support/love from you man!!! 
But also happy (very) my money is not in your "fund".....

:-) 
PS: glad i went to PDSB 
pointless remark piet. Why are you even on here anymore?



<< Previous
Bullboard Posts
Next >>